Interview: How Tragedy Changed the FDA
As an FDA advisory committee prepares to weigh whether specialized pharmacies should be allowed to dispense seven unapproved peptides, Mikkael A. Sekeres, a scientist and former adviser, discusses the history and nuances of FDA oversight, including its process for screening advisory committee members for conflicts of interest.
We haven't written up this one. Undark has the full story — the link below goes straight to it.
